Fig. 6

Kaplan-Meier analysis of the nomogram-based lymph node metastasis (A) and pathological lymph node metastasis (B) for predicting 2-year disease-free survival (DFS) in patients with gastric cancer in the whole groups
Kaplan-Meier analysis of the nomogram-based lymph node metastasis (A) and pathological lymph node metastasis (B) for predicting 2-year disease-free survival (DFS) in patients with gastric cancer in the whole groups